ABVC BioPharma, Inc.
ABVC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,247 | -$2,257 | -$944 | $229 |
| Dep. & Amort. | $96 | $81 | $114 | $179 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,136 | $1,572 | $49 | -$184 |
| Change in WC | -$141 | -$389 | -$19 | -$222 |
| Other Non-Cash | $22 | $100 | $261 | -$496 |
| Operating Cash Flow | -$133 | -$894 | -$540 | -$494 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$1,273 | -$666 | $0 | $0 |
| Investing Cash Flow | -$1,273 | -$666 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $150 | $0 | -$29 | $0 |
| Stock Issued | $0 | $0 | $412 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$7 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $982 | $1,927 | $46 | $589 |
| Financing Cash Flow | $1,132 | $1,927 | $429 | $581 |
| Forex Effect | $52 | -$51 | $7 | $6 |
| Net Chg. in Cash | -$222 | $317 | -$104 | $94 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,076 | $760 | $864 | $770 |
| End Cash | $854 | $1,076 | $760 | $864 |
| Free Cash Flow | -$133 | -$894 | -$540 | -$494 |